Barely Significant
← all excerpts

Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma.

Transl Oncol · 2019 · PMC6187100 · PMID 30316146

Europe PMCDOI
1
hedged sentence
0.1300
closest p · 2.6× alpha
0.1300
boldest claim

The sentences

showed a trendP = .13not close (p > 0.1)
Survival curves showed a trend towards improved survival (assessed by number of mice with tumor volume <500 mm 3 ) in mice treated with CX-4945 alone compared to controls ( P = .13) ( Figure 5 B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.